Actoverco’s Active participation in the 21st International Congress on Cardiovascular Updates in Milad Tower International Conference Hall

Author:
Actoverco
Date:
12 August 2019
34

This congress started on August 20 and will continue until tomorrow, August 23.

This congress started on August 20 and will continue until tomorrow, August 23.

Actoverco currently has 10 active drugs on the market in three lines related to the field of cardiovascular disease, and plans to launch at least two other new drugs in this field by the end of this year.

Related Posts

4R4A061511-2048x1365

Atipharmed Supports the 6th International Congress on Minimally Invasive Techniques in Gynecology and Endometriosis

27 January 2025
M_HA2443

Scientific Conference on the Effects of Hormone Replacement Therapy (HRT) in Menopause

29 December 2024
4R4A3160

Holding the 21st MS Congress of Iran with the participation of Actoverco

15 December 2024
M_HA1634

Presentation of Actover’s latest products at the Gastrointestinal and Liver Diseases Congress

11 December 2024
4R4A2655-Pano

Introduction of Actoverco Cardiovascular Medications at the 8th International Heart Failure Congress

8 December 2024